ArticleCureus2025
Miliary Nodules in the Lungs Not Always Due to Tuberculosis: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic bronchopulmonary aspergillosis (ABPA) is a disease that occurs due to a pulmonary immune system reaction to the antigens of Aspergillus Fumigatus. Central bronchiectasis, mucoid impaction, mosaic attenuation, centrilobular nodules, and tree-in-bud opacities are the most commonly observed CT scan findings of ABPA. Miliary molting is one of the rare radiological manifestations of ABPA. ABPA is usually seen in uncontrolled asthma and is very uncommon in patients without a prior history of asthma. We are reporting a case of ABPA that presented a miliary nodule in radiology and was never diagnosed as a case of asthma previously. Thus, in a patient with eosinophilia and miliary molting, ABPA is to be excluded. Early diagnosis and treatment can prevent end-stage fibrotic ABPA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.